Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

23 Sept 2014

Abstract excerpt

There is an urgent need to develop approaches for repairing the damaged heart, discovering new therapeutic drugs that do not have toxic effects on the heart, and improving strategies to accurately model heart disease. The potential of exploiting human induced pluripotent stem cell (hiPSC) technology to generate cardiac muscle "in a dish" for these applications continues to generate high enthusiasm. In recent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital heart defects research
Share to Pluripotent Stem Cells Research
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25286293
DOI: 10.3791/52010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow CytometryPMID 25286293Read ↗

Primitive Cardiac Cells from Human Embryonic Stem CellsSemantic proximity Read ↗

A Simple, Cost-Effective but Highly Efficient System for Deriving Ventricular Cardiomyocytes from Human Pluripotent Stem CellsSemantic proximity Read ↗

A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline VariabilitySemantic proximity Read ↗

Induced Pluripotent Stem Cells Technology and Cardiomyocyte Generation: Progress, Uncertainties and Challenges in the Biological Features and Clinical ApplicationsSemantic proximity Read ↗

APLNR marks a cardiac progenitor derived with human induced pluripotent stem cellsSemantic proximity Read ↗

Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes.Semantic proximity Read ↗

Are these cardiomyocytes? Protocol development reveals impact of sample preparation on the accuracy of identifying cardiomyocytes by flow cytometrySemantic proximity Read ↗

High-purity enrichment of functional cardiovascular cells from human iPS cells.Semantic proximity Read ↗

Generation of Functional Murine Cardiac Myocytes From Induced Pluripotent Stem CellsSemantic proximity Read ↗

Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem CellsSemantic proximity Read ↗

Effective Cardiac Myocyte Differentiation of Human Induced Pluripotent Stem Cells Requires VEGFSemantic proximity Read ↗

Heart regeneration with human pluripotent stem cells: Prospects and challengesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.